These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33619803)

  • 21. Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients.
    Nair N; Hu Z; Du D; Gongora E
    World J Transplant; 2021 Mar; 11(3):54-69. PubMed ID: 33816146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
    Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
    J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck.
    Bobin C; Ingrand P; Dréno B; Rio E; Malard O; Espitalier F
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Apr; 135(2):99-103. PubMed ID: 29100720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
    Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Covering of parotid and cervical lymph nodes metastasis of cutaneous squamous cell carcinoma of the head, about 18 cases].
    Vatin L; Morvan JB; Rivière D; Okremchouk I; Abed S; Verdalle P
    Rev Laryngol Otol Rhinol (Bord); 2015; 136(1):9-15. PubMed ID: 26749599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
    Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
    J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
    Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
    Blokx WA; Ruiter DJ; Verdijk MA; de Wilde PC; Willems RW; de Jong EM; Ligtenberg MJ
    Am J Surg Pathol; 2005 Jan; 29(1):125-30. PubMed ID: 15613867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous squamous cell carcinoma and mortality in end-stage renal disease.
    Jung J; Waller JL; Tran S; Baer SL; Kheda M; Mohammed A; Padala S; Young L; Siddiqui B; Bollag WB
    Am J Med Sci; 2023 Mar; 365(3):249-257. PubMed ID: 36403674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.
    Orte Cano C; Van Meerhaeghe T; Tannous J; Lienard D; Van Gestel D; Cuylits N; Luce S; Carlot S; Le Moine A; Aspeslagh S; Del Marmol V
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():53-58. PubMed ID: 34855244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
    Van Meerhaeghe T; Baurain JF; Bechter O; Orte Cano C; Del Marmol V; Devresse A; Doubel P; Hanssens M; Hellemans R; Lienard D; Rutten A; Sprangers B; Le Moine A; Aspeslagh S
    Front Nephrol; 2022; 2():1041819. PubMed ID: 37675002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
    McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
    Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
    Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
    J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of sentinel lymphatic node biopsy in detection of early micrometastases in patients with cutaneous squamous cell carcinoma.
    Samsanavicius D; Kaikaris V; Cepas A; Ulrich J; Makstiene J; Rimdeika R
    J Plast Reconstr Aesthet Surg; 2018 Apr; 71(4):597-603. PubMed ID: 29174519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients.
    Hanania HL; Lewis DJ
    J Dermatolog Treat; 2022 Dec; 33(8):3119-3126. PubMed ID: 36018250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.